On November 5, 2024, Novo Nordisk A/S, a leading global healthcare company, announced the completion of its share repurchase programme that was initiated on August 7, 2024. The programme, conducted under the Safe Harbour Rules, was part of a larger 12-month share repurchase plan set to run from February 6, 2024, with a total budget of up to DKK 20 billion. The concluded programme saw Novo Nordisk repurchasing B shares amounting to DKK 2.4 billion between August 7 and November 4, 2024. During the final week of the programme, the company bought back shares with transaction values ranging from DKK 36,745,162 to DKK 38,491,780, at average prices between DKK 757.63 and DKK 776.08. By the end of the programme, Novo Nordisk had acquired a total of 2,824,723 B shares for DKK 2,399,999,603. As a result, Novo...Show More

On November 5, 2024, Novo Nordisk A/S, a leading global healthcare company, announced the completion of its share repurchase programme that was initiated on August 7, 2024. The programme, conducted under the Safe Harbour Rules, was part of a larger 12-month share repurchase plan set to run from February 6, 2024, with a total budget of up to DKK 20 billion. The concluded programme saw Novo Nordisk repurchasing B shares amounting to DKK 2.4 billion between August 7 and November 4, 2024. During the final week of the programme, the company bought back shares with transaction values ranging from DKK 36,745,162 to DKK 38,491,780, at average prices between DKK 757.63 and DKK 776.08. By the end of the programme, Novo Nordisk had acquired a total of 2,824,723 B shares for DKK 2,399,999,603. As a result, Novo Nordisk now holds 15,220,480 B shares as treasury shares, which represents 0.3% of the share capital. The company's total share count, including treasury shares, stands at 4,465,000,000. Since the beginning of the larger repurchase plan on February 6, 2024, Novo Nordisk has bought back 13,891,849 B shares at an average price of DKK 873.01 per share, totaling DKK 12,127,705,653 in value. Novo Nordisk's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.